Advanced Glycation Endproducts
AGEs
AGEs play a pivotal role in the development of chronic age-related diseases such as diabetes, renal failure and cardiovascular disease.
Measuring AGEs
Until now it has been complicated to measure tissue advanced glycation endproducts (AGEs) in patients as existing methods are expensive, time consuming, lack specificity, are poorly reproducible and/or are invasive.
The AGE Reader is therefore the answer to the need for measuring AGEs without the disadvantages of the existing methods. This state of art device provides a simple non-invasive solution, allowing clinicians to determine the AGE level within 12 seconds.
AGE Reader and Tissue Fluorescence
Many AGEs have a characteristic fluorescence. Moreover, tissue fluorescence in invasive biopsies has an established association with chronic complications. The AGE Reader is able to easily, quickly and noninvasively measure this tissue fluorescence.
The AGE Reader has a light source which illuminates the tissue of interest. This light excites fluorescent moieties in the tissue which will emit light with a different wavelength as a result. In the used wavelength band the major contribution in fluorescence comes from fluorescent AGEs. The emitted light is measured with a proprietary detector.
Find out more about
Would you like to learn more about our products? Request any information you wish to receive here.
Read more »
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.